OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,835 | +45.0% | 310,500 | +6.0% | 0.01% | +75.0% |
| Q2 2023 | $2,645 | +196.5% | 292,900 | +13.9% | 0.00% | +300.0% |
| Q1 2023 | $892 | +36.8% | 257,200 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $652 | -99.9% | 266,200 | -30.0% | 0.00% | 0.0% |
| Q3 2022 | $1,050,000 | -9.9% | 380,500 | +33.0% | 0.00% | 0.0% |
| Q2 2022 | $1,165,000 | +10.5% | 286,134 | +15.7% | 0.00% | 0.0% |
| Q1 2022 | $1,054,000 | -60.9% | 247,332 | +152.6% | 0.00% | -66.7% |
| Q3 2021 | $2,698,000 | – | 97,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |